Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)

American Journal of Medical Genetics

Volumn 68, Issue 3, 1997, Pages 305-310

  Elias, Ellen R ^a,c   Irons, Mira B ^a   Hurley, Anne D ^a   Tint, G Stephen ^b   Salen, Gerald ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

7 dehydrocholesterol (7 DHC); cholesterol therapy; Smith Lemli Opitz syndrome (SLOS)

Indexed keywords

ARTICLE; CHILD; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; DIET SUPPLEMENTATION; FAT INTAKE; FEMALE; HUMAN; INFANT; MALE; NEWBORN; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME; TREATMENT OUTCOME;

BEHAVIOR; BILE ACIDS AND SALTS; CATARACT; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, DIETARY; ENDOCRINE GLANDS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; GROWTH; HUMANS; INFANT; INFANT, NEWBORN; INFECTION; MALE; SKIN DISEASES; SMITH-LEMLI-OPITZ SYNDROME;

EID: 0031050244     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19970131)68:3<305::AID-AJMG11>3.0.CO;2-X     Document Type: Article

References (8)

1. Barbu V, Roux C, Lambert D, Dupuis R, Gardctte J, Maziere J-C, Maziere C, Elefant E, Polonovski J (1988): Cholesterol prevents the teratogenic action of AY9944: Importance of the timing of cholesterol supplementation to rats. J Nutr 118:774-779.
2. Irons M, Elias ER, Sälen G, Tint GS, Batta AK (1993): Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome (Letter to the Editor). Lancet 341:1414.
3. Irons M, Elias ER, Tint GS, Sälen G, Frieden R, Buie TM, Ampola M (1994): Abnormal cholesterol metabolism in the Smith-LemliOpitz syndrome: Report of clinical and biochemical findings in 4 patients and treatment in 1 patient. Am J Med Genet 50:347-352.
4. Irons M, Elias ER, Abuelo D, Tint GS, Sälen G (1995a): Clinical features of the Smith-Lemli-Opitz syndrome and treatment of the cholesterol metabolic defect. Int Peds 10:28-32.
5. Irons M, Elias ER, Nwokoro NA, Mulvihill JJ, Bull MJ, Keppen L (1995b): Fat-soluble vitamins in the Smith-Lemli-Opitz (SLO) syndrome. Program and s of the 2nd Annual Joint Conf., March of Dimes/ACMG, Los Angeles, CA.
6. Tint GS, Irons M, Elias ER, Batta AK, Sälen G, Frieden R, Chen TS (1994): Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330:107-113.
7. Wang X, Hoffmann AF, Tso P (1995): Inhibition of cholesterol absorption by sodium ursodeoxycholyl taurine. Gastroenterology 108:A1196.
8. Xu G, Sälen S, Shefer S, Ness GC, Chen TS, Zhao Z, Sälen G, Tint GS (1995): Treatment of the cholesterol biosynthetic defect as seen in the Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766-The effect of cholesterol, cholic acid, lovastatin and their combinations. Gastroenterology 109:1301-1307.